Related Experiment Video
Updated: May 14, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Analysis of IL-17 gene polymorphisms in Chinese patients with dilated cardiomyopathy
Ying Peng1, Bin Zhou, Yan-Yun Wang
1Department of Cardiology, West China Hospital of Sichuan University, Chengdu, PR China.
Insights
Interleukin 17 (IL-17) gene variations were studied for their link to dilated cardiomyopathy (DCM) risk in a Chinese population. While no overall association was found, one IL-17F polymorphism showed a potential link in male patients.
Area of Science:
- Genetics
- Cardiology
- Immunology
Background:
- Dilated cardiomyopathy (DCM) is a leading cause of heart failure and sudden cardiac death.
- Interleukin 17 (IL-17) is a pro-inflammatory cytokine implicated in various disease processes.
- Understanding genetic predispositions to DCM is crucial for risk stratification and management.
Purpose of the Study:
- To investigate the association between IL-17A and IL-17F gene polymorphisms and the risk of developing DCM.
- To evaluate specific single nucleotide polymorphisms (SNPs) within the IL-17A and IL-17F genes.
- To assess these genetic factors in a Chinese Han population.
Main Methods:
- A case-control study design was employed.
- 288 DCM patients and 421 healthy controls were recruited.
- TaqMan® SNP Genotyping Assay was used to analyze IL-17A (rs2275913) and IL-17F (rs763780) polymorphisms.
Main Results:
- No significant differences in genotypic or allelic frequencies were observed between DCM patients and controls overall.
- Stratified analysis indicated a potential association between IL-17F SNP rs763780 and DCM risk in male patients under a dominant genetic model (p=0.031, OR=1.83).
- The tested IL-17A SNP rs2275913 showed no association with DCM in the studied population.
Conclusions:
- The studied IL-17A and IL-17F gene polymorphisms (rs2275913 and rs763780) are not generally associated with DCM risk in the Chinese population.
- A specific IL-17F polymorphism (rs763780) may have a role in DCM susceptibility among males, warranting further investigation.
- These findings contribute to understanding the genetic landscape of DCM and the role of inflammatory cytokines.
Abstract:
Cardiomyopathy is one of the major causes of sudden death and/or progressive heart failure. Dilated cardiomyopathy (DCM), comprising 60% of the cases of identified cardiomyopathy, is the most common form of heart muscle disease. Interleukin 17 (IL-17) is a proinflammatory cytokine that has been implicated in the pathogenesis of various diseases. To evaluate the influence of IL-17A and IL-17F gene polymorphisms on the risk of DCM, a case-control study was conducted in a Chinese Han population. The TaqMan® SNP Genotyping Assay was used to genotype the SNP rs2275913 of IL-17A and SNP rs763780 of IL-17F in 288 DCM patients and 421 ethnicity-matched controls. No significant difference in genotypic and allelic frequencies between DCM patients and control subjects was observed. However, Results of stratified analysis revealed that rs763780 was associated with male DCM patients in a dominant genetic model (p=0.031, OR=1.83, 95% CI=1.04-3.22). Our results suggest that the tested two IL-17 SNPs, rs2275913 and rs763780, are not found to be associated with DCM in the Chinese population studied.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Single Nucleotide Polymorphisms-SNPs
Cardiomyopathy IV: Restrictive Cardiomyopathy
